Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer is a research paper published in Translational Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Virginia Commonwealth University
Grant: UL1TR002649
Susan G. Komen
Grant: CCR19608826
National Cancer Institute
Grant: 1R01CA185189
National Cancer Institute
Grant: 1R01CA246182–01A1
National Cancer Institute
Grant: P30 CA016059
NCI NIH HHS
Grant: R01 CA246182
NCI NIH HHS
Grant: R01 CA185189
National Institutes of Health
Grant: 5UL1TR002649-02
Center for Clinical and Translational Research
National Institutes of Health
Grant: 3R01CA246182-04S1
Circumventing acquired carboplatin resistance in triple-negative breast cancers
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
National Institutes of Health
Grant: 1R01CA185189-01
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
Thomas F. and Kate Miller Jeffress Memorial Trust
National Center for Advancing Translational Sciences
National Institutes of Health
FWCI
0.81
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals